Intellia Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

World News: . []

CAMBRIDGE Mass March 14 2018 GLOBE NEWSWIRE -- Intellia Therapeutics Inc NASDAQNTLA a leading genome editing company focused on developing curative therapeutics using CRISPR technology announced financial results and operational progr ess for...

More news and information about Intellia Therapeutics, Inc.

Published By:

Globe Newswire: 11:30 GMT Wednesday 14th March 2018

Published: .

Search for other references to "intellia" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us